Pragmatic function impairment and Alzheimer’s dementia
Pragmatic competence includes the capacity to express illocutionary force and successfully achieve perlocutionary effects, in order to guarantee fully functional communication exchanges. Alzheimer’s Disease is characterized by a constellation of limitations derived from progressive cognitive impairment, which is usually viewed as a global uniform phenomenon. In this paper it is argued that looking independently at the loss and recovery of pragmatic function related to illocutionary and perlocutionary abilities can be a productive way of understanding the progressive deterioration of communicative capacities by patients or their improvement under targeted treatment.
Keywords: Alzheimer's Disease, illocutionary and perlocutionary acts, performative utterances, pragmatic functions, cognitive impairment
Published online: 20 July 2017
Appell, J., Kertesz, A, and Fisman, M.
Arab, L., Sadeghi, R., Walker, D.G, Lue, L-F. and Sabbagh, M.N.
Blair, M., Ceclie, A.M., Nicole, D-F. and Andrew, K.
Boyé, M., Grabarb, N. and Tran, M.
Chen, X.Q., Fawcett, J.R., Rahman, A. and Frey II, W.H.
Chen, X.Q., Fawcett, J.R., Rahman, A.a and Frey II, W.H.
Claxton, A., Baker, L., Hanson, A., Trittschuh, E., Cholerton, B., Morgana, C., M., Arbuckle, M., Behl, C. and Craft, S.
Craft, S., Baker, L., Montine, T., Minoshima, S., Watson, S., Claxton, A., Arbuckle, M., Callaghan, M., Tsai, E., Plymate, S., Green, P., Leverenz, J., Cross, D. and Gerton, B.
Craft, S., Claxton, A., Hanson, A., Cholerton, B., Neth, B., Trittschuh, E. and Baker, L.
de Vugt, M.E.
DSM-IV-TR, Alzheimer’s Disease. American Psychiatric Association
Grand, J.H., Caspar, S. and MacDonald, S.W.
2009 Patient interviews, HBO, “The Connection The Connection between Insulin and Alzheimer’s”. http://www.hbo.com/alzheimers/the-supplementary-series.html.
Helkala, E.L., Laulumaa, V., Soininen, H. and Riekkinen, P.J.
Hsieh, S., Muireann, I., Naomi, D., John R.H. and Olivier, P.
Kurve Technology, Inc
2015 Lynwood, Washington.
Mentis, M., Briggs-Whittaker, J. and Gramigna, G.D.
Petrides, M., Alivisatos, B., Meyer, E. and Evans, A.C.
Ragin, C.C. and Howard, S.B.
Reisberg, B., Ferris, S.H., de Leon, M.J. and Crook, T.
Reger, M.A., Watson, G.S., Frey, W.H. 2nd, Baker, L.D., Cholerton, B., Keeling, M.L., Belongia, D.A., Fishel, M.A., Plymate, S.R., Schellenberg, G.D., Cherrier, M.M. and Craft, S.
Reger, M.A., Watson, G.S., Green, P.S., Baker, L.D., Cholerton, B., Fishel, M.A., Plymate, S.R., Cherrier, M.M., Schellenberg, G.D., Frey, W.H. 2nd, and Craft, S.
Schioth, C., Brooks, Frey II and Benedict, C.
Schroeter, M.L., Stein, T., Maslowski, N., and Neumann, J.
Shemesh, E., Rudich, A., Harman-Boehm, I. and Cukierman-Yaffe, T.
Shune, S. and Duff, M.
Shany-Ur, T., Nancy, L., Howard, J.R., Marc, S., Bruce, L.M. and Katherine P. Rankin
2015 “The study of nasal insulin in the fight against forgetfulness”. www.clinicaltrials.gov, identifier-NCT01767909.
Tappen, R., Williams, C., Barry, C. and DiSesa, D.
Thorne, R.G. Emory, C.R., Ala, T.A. and Frey, W.H. Jr
University of San Francisco Memory and Aging Center
Zanetti, O., Frisoni, G.B., Bianchetti, A., Tamanza, G., Cigoli, V. andTrabucchi, M.
Cited by 2 other publications
Schatz, Sara & Melvin González-Rivera
This list is based on CrossRef data as of 17 march 2021. Please note that it may not be complete. Sources presented here have been supplied by the respective publishers. Any errors therein should be reported to them.